OMC
KRON

Oasis Management Company’s Kronos Bio KRON Stock Holding History

Oasis Management Company’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-196,078
Closed -$318K – 96
2022
Q4 		$318K Hold
196,078
– – 0.06% 83
2022
Q3 		$657K Hold
196,078
– – 0.11% 75
2022
Q2 		$714K Buy
+196,078
New +$889K 0.13% 68

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Oasis Management Company's KRON Position: Q1 2023 in Review

Oasis Management Company sold out of Kronos Bio (KRON) in Q1 2023, closing a stake of 196,078 shares — an estimated $318K sold.

Oasis Management Company first reported a position in KRON in Q2 2022 and held it in 3 quarters. The position peaked at $714K in Q2 2022. 87 funds tracked by Wall St. Rank hold KRON as of Q1 2023.

  • Oasis Management Company reported no remaining Kronos Bio position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 196,078 Kronos Bio shares in Q1 2023, an estimated $318K.
  • Oasis Management Company first reported a position in Kronos Bio in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Kronos Bio position peaked at $714K in Q2 2022.
  • 87 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.